Kovack Advisors, Inc. Amarin Corp Plcuk Transaction History

Kovack Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$1.13 - $3.69 $12,429 - $40,590	-11,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $31,350 - $41,030	11,000 New	11,000 $36,000
Q3 2020 Nov 02, 2020	SELL	$3.64 - $7.76 $44,772 - $95,448	-12,300 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$4.78 - $8.26 $58,794 - $101,598	12,300 New	12,300 $85,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $198M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Kovack Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Kovack Advisors, Inc. with notifications on news.